Gano Kyle

CIK 00015671601 companySAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001567160

Recent Transactions

50 trades

Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2026-01-16$35.99/sh+1,812→ 142,219 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2026-01-16$35.99/sh+34,588→ 174,995 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Incentive Stock Option
2026-01-16−1,812→ 0 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2026-01-16$132.70/sh−34,588→ 140,407 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2026-01-16$132.71/sh−1,812→ 140,407 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2026-01-16−34,588→ 0 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-11-04$141.97/sh−300→ 140,407 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-11-01−613→ 1,842 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-11-01+613→ 140,720 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-13+2,241→ 141,113 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-13+2,566→ 140,224 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-02-13−2,241→ 6,725 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-13$116.86/sh−1,206→ 139,907 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-13$116.84/sh−1,352→ 138,872 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-02-13−2,566→ 5,132 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-02-12+19,628→ 19,628 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Stock Option
2025-02-12+104,736→ 104,736 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-10$118.39/sh−980→ 137,658 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-08+1,860→ 138,638 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-02-08−1,860→ 0 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-01-31+2,927→ 138,319 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-01-31−2,927→ 2,927 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-01-31$152.87/sh−1,541→ 136,778 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-01-15$32.99/sh+4,812→ 140,204 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-01-15$141.50/sh−4,812→ 135,392 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-01-15$32.99/sh+60,188→ 195,580 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-01-15$141.50/sh−60,188→ 135,392 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Incentive Stock Option
2025-01-15−4,812→ 0 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2025-01-15−60,188→ 0 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Stock Option
2024-11-01+13,344→ 13,344 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2024-11-01+2,455→ 2,455 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2024-02-13+8,966→ 8,966 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Stock Option
2024-02-13+45,058→ 45,058 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-02-13$132.89/sh−1,352→ 135,166 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-02-08$134.20/sh−980→ 133,952 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-02-06$142.20/sh−1,600→ 133,072 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-01-31$140.70/sh−1,541→ 131,635 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Incentive Stock Option
2024-01-02$19.59/sh−6,116→ 0 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2024-01-02$19.59/sh−68,884→ 0 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-01-02$131.44/sh−6,116→ 130,250 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-01-02$19.59/sh+6,116→ 136,366 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-01-02$19.59/sh+68,884→ 199,134 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-01-02$131.47/sh−68,884→ 130,250 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-08-21$107.41/sh−2,132→ 130,250 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2023-02-13+10,264→ 10,264 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Stock Option
2023-02-13+63,789→ 63,789 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-02-08$103.99/sh−980→ 128,096 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-02-07$102.29/sh−1,623→ 115,719 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-02-07$102.41/sh−12,801→ 127,216 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-02-06$105.64/sh−1,600→ 114,257 total

Companies

NEUROCRINE BIOSCIENCES INC
Director, Chief Executive Officer
$NBIX

Recent Filings

Address

6027 EDGEWOOD BEND CT.

SAN DIEGO, CA, 92130

View on SEC.gov